The authors found concordance in the mutations of the key genes involved in lung cancer progression, such as cytokerain-8, cytokeratin-18, thyroid transcription factor 1 (TTF-1) and epidermal growth factor receptor (EGFR), both in expanded CTCs and primary tumors. This evidence concerns the gene EGFR and lung carcinoma.